Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models

Research output: Contribution to journalArticlepeer-review

Abstract

In countries with a healthcare system mostly financed by public sources (such as Australia and the United Kingdom), timely patient access to new effective health technologies (eg, medical services, medicines) is one of their central objectives.1,2 Expediting access to innovative technologies can lead to improvements in health outcomes and can drive continued innovation in the health system. There are likely to be multiple factors influencing delays in patient access to new health technologies such as the efficiency of the health technology assessment (HTA) review processes (including multiple layers of decision making), criteria to inform funding decisions (including lack of clarity in HTA evidence requirements), and budget constraints.3

Original languageEnglish
Pages (from-to)755-758
Number of pages4
JournalValue in Health
Volume24
Issue number6
Early online date13 Mar 2021
DOIs
Publication statusPublished - Jun 2021

Keywords

  • decision analytic modeling
  • decision making
  • economic evaluation
  • health technology assessment

Fingerprint

Dive into the research topics of 'Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models'. Together they form a unique fingerprint.

Cite this